Victoria Ling

688 total citations
12 papers, 270 citations indexed

About

Victoria Ling is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Victoria Ling has authored 12 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Victoria Ling's work include Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Victoria Ling is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Epigenetics and DNA Methylation (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). Victoria Ling collaborates with scholars based in Australia, Germany and Canada. Victoria Ling's co-authors include Grace Bradley, Clemente Cillo, John E. Dick, Ioannis Zabetakis, David Westerman, Megan J. Bywater, Susan Morgan, Eric Wong, Surender Juneja and Florian H. Heidel and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Pathology and Leukemia.

In The Last Decade

Victoria Ling

9 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Victoria Ling Australia 6 143 140 35 28 21 12 270
Shachar Raz Israel 7 206 1.4× 99 0.7× 78 2.2× 28 1.0× 18 0.9× 7 311
Maria Rovithi Netherlands 12 127 0.9× 170 1.2× 73 2.1× 17 0.6× 13 0.6× 22 337
Susan Wittig Germany 13 235 1.6× 120 0.9× 28 0.8× 58 2.1× 27 1.3× 25 387
Daniel Nguyen United States 10 146 1.0× 91 0.7× 65 1.9× 52 1.9× 14 0.7× 22 326
Limin Huang China 8 157 1.1× 65 0.5× 96 2.7× 25 0.9× 12 0.6× 22 311
J.L. Merlin France 9 149 1.0× 179 1.3× 30 0.9× 63 2.3× 23 1.1× 22 299
W. S. Dalton United States 6 176 1.2× 214 1.5× 29 0.8× 40 1.4× 34 1.6× 6 328
Elke Malenke Germany 9 126 0.9× 82 0.6× 22 0.6× 30 1.1× 24 1.1× 13 303
Sanglin Li China 10 207 1.4× 81 0.6× 106 3.0× 21 0.8× 10 0.5× 16 387
Anna Hagenkort Sweden 6 255 1.8× 145 1.0× 50 1.4× 9 0.3× 6 0.3× 6 361

Countries citing papers authored by Victoria Ling

Since Specialization
Citations

This map shows the geographic impact of Victoria Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria Ling more than expected).

Fields of papers citing papers by Victoria Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria Ling. The network helps show where Victoria Ling may publish in the future.

Co-authorship network of co-authors of Victoria Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria Ling. A scholar is included among the top collaborators of Victoria Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria Ling. Victoria Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chopra, Sakshi, Victoria Ling, Ruth E. Hubbard, et al.. (2025). Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: A systematic review. Journal of Geriatric Oncology. 16(3). 102196–102196.
2.
Ling, Victoria, Florian H. Heidel, & Megan J. Bywater. (2024). Pathogenesis and management of high molecular risk myeloproliferative neoplasms. Haematologica. 110(4). 863–876. 5 indexed citations
3.
Straube, Jasmin, Therese Vu, Björn von Eyß, et al.. (2023). Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia. Leukemia. 37(4). 741–750. 1 indexed citations
4.
Ling, Victoria, Jasmin Straube, William Godfrey, et al.. (2022). Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia. Leukemia. 37(1). 143–153. 25 indexed citations
5.
Ling, Victoria & Ioannis Zabetakis. (2021). The Role of an Anti-Inflammatory Diet in Conjunction to COVID-19. SHILAP Revista de lepidopterología. 9(4). 76–76. 15 indexed citations
6.
Wong, Eric, Victoria Ling, David Westerman, Susan Morgan, & Surender Juneja. (2015). How unique is pure erythroid leukaemia? A retrospective analysis of seven cases and review of the literature. Journal of Clinical Pathology. 68(4). 301–305. 14 indexed citations
7.
Ling, Victoria, et al.. (2014). A dimorphic blast population demonstrates Philadelphia-positive mixed phenotype acute leukaemia. Pathology. 46(3). 244–246. 1 indexed citations
8.
9.
Ling, Victoria. (2012). The Lower Palaeolithic Colonisation of Europe: Antiquity, Magnitude, Permanency and Cognition. 1 indexed citations
10.
Deboer, George, J E Kingston, Gideon Koren, et al.. (1994). Cyclosporin-modulated chemotherapy with focal cryo/laser therapy. Anti-Cancer Drugs. 5. 57–57. 1 indexed citations
11.
Bradley, Grace, et al.. (1989). P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.. PubMed. 49(10). 2790–6. 134 indexed citations
12.
Cillo, Clemente, et al.. (1987). Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.. PubMed. 47(10). 2604–8. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026